Lungekreft
- Auranofin
- Benzaldehyde i syklodekstrin
- Cantron
- Cannabisolje
- Ellagic acid
- DCA
- Delta-tocotrienol
- Diklofenak
- Disulfiram
- Dobesilate
- Flor essence
- Hydrogen
- IDO-hemmere + HDCA-hemmere + sjekkpunk-hemmere
- Itraconazole
- Kryoablasjon sammen med sjekkpunkt-hemmere
- Mariatistel
- Melatonin (15-40 mg daglig) (N), (R)
- Mifepristone
- Mito-honokiol
- Nbg 24:7 (Norsk beta glukan) (N)
- Nordic naturals DHA (N)
- Oleander
- Osimertinib (L)
- Pamidronate (L)
- Pau d`arco te/beta-lapachone
- Protocel
- Selen (N)
- Sulindac (L)
- Tetrathiomolybdate
- Vitamin D
Ikke-småcellet lungekreft
- Sunvozertinib (Zegfrovy) (L) – målrettet EGFR-hemmer ved påviste EGFR exon 20-innsettingsmutasjoner (EGFR ex20ins) i ikke-småcellet lungekreft (NSCLC). I USA fikk legemidlet akselerert godkjenning 2. juli 2025 for voksne med lokalavansert eller metastatisk sykdom som har utviklet seg under eller etter platinabasert cellegift.
Spindelcelle karsinom
- Germanium sesquioxide
- TCM - Ma-xing-shi-gan (MXSG)
Grupper
- https://egfrcancer.org/
Kilder
- Recent Advances in Immunotherapy in Metastatic NSCLC. Front Oncol. 2016; 6: 239.
- Mifepristone Extends Both Length and Quality of Life in a Patient With Advanced Non-small Cell Lung Cancer that Has Progressed Despite Chemotherapy and a Check-point Inhibitor. Anticancer Research April 2019 vol. 39 no. 4 1923-1926
- Combination of Local Ablative Therapy and Continuation of Immune Checkpoint Inhibitor (ICI) Therapy Provides Durable Treatment Response Past Oligometastatic Progression in NSCLC: A Case Report. Case Rep Oncol 2019;12:866–871
- Melatonin and non-small cell lung cancer: new insights into signaling pathways. Cancer Cell International volume 19, Article number: 131 (2019)
- Melatonin as a potential anticarcinogen for non-small-cell lung cancer. Oncotarget. 2016 Jul 19; 7(29): 46768–46784
- Long-term survival in a patient with pulmonary spindle cell carcinoma treated with traditional Chinese medicine. BMJ Case Rep. 2018; 2018: bcr2018225989.
- Dramatic response to inhaled dobesilate in a patient with lung squamous cell cancer. BMJ Case Rep. 2012; 2012: bcr2012006622.
Published online 2012 Sep 5. - https://www.cancertreatmentsresearch.com/hydrogen/
- FDA: Akselerert godkjenning av sunvozertinib ved EGFR exon 20-innsettingsmutasjoner. 2. juli 2025.
- DailyMed: Zegfrovy (sunvozertinib) – amerikansk preparatomtale. Revidert august 2026.